Medical Biotechnology Group, Department of Biotechnology, Ministry of Science and Technology, Lodi Road, New Delhi 110 003, India.
J Biosci. 2021;46.
Cancer is a group of diseases with major societal impact and accounts for approximately 55 percent of mortality in India. The Indian population is increasing in size and gradually ageing. As a result, the number of people diagnosed with and dying of cancer are increasing. Government funding agencies such as the Department of Biotechnology (DBT) has a clear definitive role in the management and control of cancer. Through Research and Development programs and multi-institutional networking programs, DBT has provided resources to individual investigators and to institutions, to carry out basic, applied, translational and clinical research and to develop new methods to prevent and treat disease and to conduct research especially in challenging areas pertaining to different types of cancer. This article summarizes the funding provided by DBT for different cancer research programs.
癌症是一组具有重大社会影响的疾病，约占印度 55%的死亡率。印度人口不断增加，且人口逐渐老龄化。因此，被诊断出患有癌症和死于癌症的人数正在增加。政府资助机构（如生物技术部（DBT））在癌症的管理和控制方面具有明确的作用。通过研究与开发计划和多机构网络计划，DBT 为个别研究人员和机构提供了资源，以开展基础、应用、转化和临床研究，并开发预防和治疗疾病的新方法，特别是在与不同类型癌症相关的具有挑战性的领域进行研究。本文总结了 DBT 为不同癌症研究计划提供的资金。
